Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Pyridoxal 5’-phosphate (active vitamin B6)

Pyridoxal-5-Phosphate (P-5-P) · also known as P-5-P, Active B6, Pyridoxine phosphate

Pyridoxal 5’-phosphate is the active form of vitamin B6. It is a coenzyme for several amino acid decarboxylases and takes part in making neurotransmitters such as dopamine, serotonin and GABA. Whether supplementation raises brain neurotransmitter levels in well-nourished people has not been confirmed.

Typical dose: The usual dose is 20–50 mg/day, taken with breakfast. For long-term use, add up total B6 intake, including diet and other supplements.
Absorption and forms: Pyridoxine hydrochloride must be converted to P-5-P in the liver in two steps before it has coenzyme activity. Oral phosphorylated forms may also lose their phosphate group during absorption. There is currently no evidence that P-5-P is safer than standard vitamin B6.

Clinical uses and human evidence

PMS and menstrual pain

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Doll 1989 · J R Coll Gen Pract · Randomized crossover trial · n=63 — Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial
  2. Williams 1985 · J Int Med Res · RCT · n=617 — Controlled trial of pyridoxine in the premenstrual syndrome

Peripheral neuropathy (numbness and tingling)

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Jacobs 2011 · Rev Neurol Dis · Open-label study · n=11 — Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate

Mechanisms of action

Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)

★★★★☆Mechanism evidence: grade B

PLP is the coenzyme for aromatic amino acid decarboxylase, which decarboxylates levodopa and 5-HTP to make dopamine and serotonin. The enzyme’s mechanism is well defined, and human studies of inherited defects support it. Whether routine supplementation increases central monoamine release in well-nourished people has not been confirmed.

References (1)
  1. Mills et al. 2005 · Human PNPO deficiency study: insufficient PLP supply is linked to abnormal aromatic amino acid decarboxylation and neurotransmitter metabolism

GABA and glutamate balance (inhibitory and excitatory tone)

★★★★☆Mechanism evidence: grade B

PLP is an essential coenzyme for glutamate decarboxylase, which converts glutamate into the inhibitory neurotransmitter GABA. Small human studies provide related biochemical evidence, but this does not guarantee that brain GABA rises in well-nourished people after supplementation.

References (2)
  1. Baumeister et al. 1994 · Case of a child with vitamin B6-dependent epilepsy: after B6 supplementation, abnormally high cerebrospinal fluid glutamate returned to normal; GABA was normal at baseline in this case
  2. Field et al. 2022 · RCT of high-dose pyridoxine: visual measures suggest an inhibitory neural effect, but GABA was not measured directly

Substrate and cofactor supply for glutathione (GSH) synthesis

★★★☆☆Mechanism evidence: grade B

PLP is a cofactor for enzymes in the transsulfuration pathway, which indirectly supports cysteine supply. Human studies provide evidence from related metabolic markers, but glutathione does not necessarily rise after supplementation, so this does not mean PLP directly raises antioxidant reserves.

References (1)
  1. Rios-Avila et al. 2015 · Small human study: related evidence from transsulfuration pathway markers, but glutathione does not necessarily rise with them

One-carbon cycle methyl donor (SAMe) regeneration and Hcy clearance

★★☆☆☆Mechanism evidence: grade B

PLP is the coenzyme for cystathionine β-synthase, which moves homocysteine into the transsulfuration pathway. In people with low B6 status, supplementation reduced the post-methionine-load rise in homocysteine. However, isotope studies did not show a clear change in remethylation flux, so this does not show that PLP directly boosts SAM regeneration.

References (2)
  1. Ubbink et al. 1996 · Study in people with low B6 status: after 20 mg/day supplementation, the post-methionine-load rise in homocysteine was smaller
  2. Rios-Avila et al. 2015 · Small human stable isotope study: B6 supplementation did not significantly change homocysteine remethylation flux

Safety and drug interactions

With long-term use, watch for sensory neuropathy; at long-term doses above 200 mg/day, sensation in the lower limbs should be monitored in particular. Even 20–50 mg/day is not guaranteed to be safe: converted to B6 equivalents, it may exceed the European Food Safety Authority (EFSA) upper limit for total adult intake of 12 mg/day.

With Levodopa Note

Levodopa/benserazide (Madopar), carbidopa/levodopa (Sinemet)

Vitamin B6 weakens the effect of levodopa taken on its own. Combination products that contain carbidopa or benserazide are generally not affected.

Open in the interactive app ›